A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family

被引:3
作者
Zhu, Ruizheng [1 ]
Xu, Jie [2 ]
Shen, Juan [1 ]
Li, Wenru [2 ]
Tan, Fei [1 ]
Li, Changchang [2 ]
Wei, Zhichen [2 ]
Liu, Yeqiang [1 ]
Bai, Yun [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Skin Dis Hosp, 1278 Baode Rd, Shanghai 200443, Peoples R China
[2] Wenzhou Hosp Integrated Tradit Chinese & Western, Wenzhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2020年 / 8卷 / 10期
关键词
CYLD cutaneous syndrome; CYLD gene; large deletion; multiple familial trichoepithelioma; mutation; BROOKE-SPIEGLER-SYNDROME; CYLINDROMATOSIS; TRICHOEPITHELIOMA; IDENTIFICATION;
D O I
10.1002/mgg3.1441
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background CYLDcutaneous syndrome (CCS; syn. Brooke-Spiegler syndrome) is a rare autosomal dominant hereditary disease characterized by multiple adnexal skin tumors including cylindromas, spiradenomas, and trichoepitheliomas. More than 100 germline mutations of the cylindromatosis (CYLD) gene have been reported in CCS and most of them are frameshift mutations or small alterations. Methods We identified a large, three-generation Chinese family with CCS, which consisted of 18 living family members, including six affected individuals. To explore the molecular biology of this family, we carried out targeted next-generation sequencing and Affymetrix CytoScan HD SNP array to analyze the mutation in theCYLDgene. Results A novel large deletion mutation, NC_000016.9:g.(50826498_50827517)_(50963389-50967346)del was found in the proband of this family. This deletion results in the loss of a nearly 140 kb fragment of theCYLDgene, spanning exons 17 similar to 20, which represent the coding regions of the ubiquitin-specific protease domain. Further quantitative polymerase chain reaction proved that all patients and two proband-related family members carried this large deletion. Conclusions Our study expands the types of mutations in CCS and will undoubtedly provide valuable information for genetic counseling for families affected by the condition.
引用
收藏
页数:7
相关论文
共 18 条
  • [11] Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene
    Parren, Lizelotte J. M. T.
    Giehl, Kathrin
    van Geel, Michel
    Frank, Jorge
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2018, 310 (07) : 599 - 606
  • [12] Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells
    Rajan, Neil
    Andersson, Mattias K.
    Sinclair, Naomi
    Fehr, Andre
    Hodgson, Kirsty
    Lord, Christopher J.
    Kazakov, Dmitry V.
    Vanecek, Tomas
    Ashworth, Alan
    Stenman, Goran
    [J]. JOURNAL OF PATHOLOGY, 2016, 239 (02) : 197 - 205
  • [13] Targeted deep sequencing of flowering regulators in Brassica napus reveals extensive copy number variation
    Schiessl, Sarah
    Huettel, Bruno
    Kuehn, Diana
    Reinhardt, Richard
    Snowdon, Rod J.
    [J]. SCIENTIFIC DATA, 2017, 4
  • [14] Vanecek T, 2014, AM J DERMATOPATH, V36, P868, DOI 10.1097/DAD.0000000000000068
  • [15] Verhoeft Krista Roberta, 2016, Cancers Head Neck, V1, P10, DOI 10.1186/s41199-016-0012-y
  • [16] The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells
    Wang, Zhangding
    Wang, Qiang
    Xu, Guifang
    Meng, Na
    Huang, Xinli
    Jiang, Zerun
    Chen, Chen
    Zhang, Yan
    Chen, Junjie
    Li, Aiping
    Li, Nan
    Zou, Xiaoping
    Zhou, Jianwei
    Ding, Qingqing
    Wang, Shouyu
    [J]. RNA BIOLOGY, 2020, 17 (11) : 1576 - 1589
  • [17] Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma
    Zhang, XJ
    Liang, YH
    He, PP
    Yang, S
    Wang, HY
    Chen, JJ
    Yuan, WT
    Xu, SJ
    Cui, Y
    Huang, W
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : 658 - 664
  • [18] LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling
    Zhao, Ming
    Xin, Xiao-Feng
    Zhang, Jian-Ya
    Dai, Wei
    Lv, Tang-Feng
    Song, Yong
    [J]. CANCER MEDICINE, 2020, 9 (03): : 1196 - 1208